Neurology® Podcast

1) Idiopathic intracranial hypertension and 2) Topic of the month: Featured speakers from the AAN Meeting. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Beau Bruce interviews Dr. Melissa Ko about her paper on idiopathic intracranial hypertension. In the next segment, Dr. Sarah Song is reading our e-Pearl of the week about carotid-cavernous fistula. In the next part of the podcast Dr. Alberto Espay interviews Dr. Serge Przedborski about his talk on Neurodegeneration: Models and mechanisms. Over the subsequent four weeks, Dr. Espay will interview other featured speakers from the AAN Meeting. The participants had nothing to disclose except Drs. Bruce, Song and Espay.Dr. Bruce has received grant funding from the AAN/AANF Practice Research Fellowship and is funded by NIH grants UL1-RR025008 and KL2-RR025009.Dr. Song served on the editorial team for the Neurology® R

1) Sydenham chorea and 2) Topic of the month: Historical interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Waugh interviews Dr. Fabienne Brilot-Turville about her paper on antibody binding to neuronal surface in Sydenham chorea. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about fragile X-associated tremor ataxia syndrome. In the next part of the podcast Dr. Farrah Mateen completes our historical interviews for the month by interviewing Dr. Jerome Posner. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Brilot-Turville, Clardy and Mateen.Dr. Brilot-Turville has received research support from the Tourette Syndrome Association, USA, the Brain Foundation Australia, and the Trish Multiple Sclerosis Fou

1) AD dementia and 2) Topic of the month: Historical interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Dr. Brad Dickerson about his paper on AD dementia in cognitively normal adults. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about ocular bobbing. In the next part of the podcast Dr. Farrah Mateen interviews Dr. Peter Dyck for our next historical interview. The participants had nothing to disclose except Drs. Dickerson, Clardy, Mateen and Dyck.Dr. Dickerson serves on the editorial board of Hippocampus; and receives research support from the NIH and the Alzheimer's Association.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Mateen served on the editorial team for the Neurology® Resident and Fellow Section and is supported by the 2010 Practice Research Grant f

1) Folic acid supplementation and 2) Topic of the month: Historical interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Nathan Fountain interviews Drs. Sheffali Gulati and Ravindra Arya about their paper on folic acid supplementation. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about the 'hot and dry foot' as a sign of cancer. In the next part of the podcast Dr. Farrah Mateen interviews Dr. C. Miller Fisher as we continue our month of historical interviews. The participants had nothing to disclose except Drs. Fountain, Gulati, Clardy and Mateen.Dr. Fountain serves on the Scientific Advisory Board and has received funding for travel from UCB; serves on the editorial board of Epilepsy Currents; estimates that 10% of his clinical effort at the University of Virginia EEG Lab is spent on EEG interpretation; receives research supp

1) Neuromyelitis optica and 2) Topic of the month: Historical interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Pearce Korb interviews Drs. Claudia Lucchinetti and Bogdan Popescu about their paper on neuromyelitis optica unique area postrema lesions. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about striatal hand and foot. In the next part of the podcast Dr. Farrah Mateen interviews Dr. Bud Rowland as part of our month of historical interviews. Over the subsequent three weeks, Dr. Mateen will interview Drs. C. Miller Fisher, Peter Dyck and Jerome Posner. The participants had nothing to disclose except Drs. Lucchinetti, Clardy, Mateen and Rowland.Dr. Lucchinetti may accrue revenue for a patent re: aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica; receives royalties from the publication of Blue Books o

1) Improvement of migraines and 2) Topic of the month: Sports neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Heather Harle interviews Dr. Dale Bond about his paper on improvement of migraines after bariatric surgery. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about hyperventilation: test for diagnosing absence seizures. In the next part of the podcast Dr. Howard Goodkin interviews Dr. Jeff Kutcher about peripheral nerve injury to finish the month about sports neurology. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Bond, Fugate and Goodkin.Dr. Bond serves on the editorial boards of Surgery for Obesity and Related Diseases and American Journal of Health Behavior; and receives research support fr

1) Traumatic brain injury and 2) Topic of the month: Sports neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Erik Ensrud and Brian Edlow interviews Dr. Jordan Grafman about his paper on traumatic brain injury. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about TCD in brain death. In the next part of the podcast Dr. Howard Goodkin interviews Dr. Jeff Kutcher about post-concussion syndrome. The LOTW for the last week of March will be about peripheral nerve injury. The participants had nothing to disclose except Drs. Grafman, Fugate and Goodkin.Dr. Grafman serves as Co-editor of Cortex and receives research support from the Intramural Research Program NIH/NINDS and the Henry M. Jackson Foundation.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Goodkin serves on the scientific boar

1) Guillain-Barré syndrome and 2) Topic of the month: Sports neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Bart Jacobs about his paper on Guillain-Barré syndrome. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about early handedness a sign of presumed perinatal stroke. In the next part of the podcast Dr. Howard Goodkin interviews Dr. Jeff Kutcher about concussion diagnosis. The LOTWs for the next two weeks of March will be post-concussion syndrome and peripheral nerve injury. The participants had nothing to disclose except Drs. Burns, Jacobs, Fugate and Goodkin.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Jacobs has received funding for travel from Baxter International Inc.; and has received research support

1) Income gap in medical practice and 2) Topic of the month: Sports neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alex Bragg interviews Dr. Bruce Sigsbee about his paper on income gap in medical practice. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about Sneddon syndrome. In the next part of the podcast Dr. Howard Goodkin interviews Dr. Jeff Kutcher about chronic traumatic encephalopathy and retirement. The LOTWs for the next three weeks of March will be concussion diagnosis, post-concussion syndrome and peripheral nerve injury. The participants had nothing to disclose except Drs. Sigsbee, Fugate and Goodkin.Dr. Sigsbee as President-Elect of the American Academy of Neurology receives a stipend.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Goodkin serves on the scientific b

1) Brain death and the courts and 2) Topic of the month: Sports neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Dan Larriviere interviews Ms Agnes Schipper about her paper on brain death and the courts. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about junctional scotoma. In the next part of the podcast Dr. Howard Goodkin interviews Dr. Jeff Kutcher about second impact syndrome and RTP. Over the subsequent four weeks, Dr. Goodkin will interview Dr. Kutcher about concussions. The participants had nothing to disclose except Drs. Larriviere, Fugate and Goodkin.Dr. Larriviere serves as a consultant for Allergan, Inc.; and serves on the editorial board of Neurology Today.Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Goodkin serves on the scientific board for Tuberous Sclerosis Al

1) Paraneoplastic disease and 2) Topic of the month: Neurotoxins. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jennie Taylor interviews Dr. Bruce Giometto about his paper on paraneoplastic disease. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about diencephalic syndrome. In the next part of the podcast Dr. Beau Bruce interviews Dr. John Pearn about ciguatera poisoning for our Lesson of the Week. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Clardy and Bruce.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce has received grant funding from the AAN/AANF Practice Research Fellowship and is funded by NIH grants UL1-RR025008 and KL2-RR025009.

1) Motor cortex inhibition and 2) Topic of the month: Neurotoxins. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interviews Dr. Don Gilbert about his paper on motor cortex inhibition. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about ictal asystole. In the next part of the podcast Dr. Beau Bruce interviews Dr. Jonathan Rutchik about neurolgic effects of organic solvents for our Lesson of the Week. Next week, we will discuss ciguatera poisoning. The participants had nothing to disclose except Drs. Gilbert, Clardy and Bruce.Dr. Gilbert has received honoraria from the Tourette Syndrome Association/ Centers for Disease Control, the Movement Disorder Society, the American Academy of Neurology, and the American Academy of Pediatrics; serves on the medical advisory board for the Tourette Syndrome Association; writes board r

1) Cerebrovascular re-events and 2) Topic of the month: Neurotoxins. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Knoflach interviews Dr. Mira Katan about her paper on stress hormones predicting cerebrovascular re-events. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about "candle guttering" sign in tuberous sclerosis. In the next part of the podcast Dr. Beau Bruce interviews Dr. David Bellinger about neurologic effects of lead toxicity for our Lesson of the Week. The Lesson of the Weeks for the last two weeks of February will be organic solvents and ciguatera poisoning. The participants had nothing to disclose except Drs. Katan, Burns, Clardy and Bruce.Dr. Katan has received speaker honoraria from B - R - A - H - M - S GmbH.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuro

1) Zoster sine herpete and 2) Topic of the month: Neurotoxins. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Don Gilden about his paper on zoster sine herpete. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about Sturge-Weber syndrome. In the next part of the podcast Dr. Beau Bruce interviews Dr. Christian Sandrock about botulism and botulinum toxin for our Lesson of the Week. Over the next subsequent three weeks, we will interview other specialists about neurotoxins. The participants had nothing to disclose except Drs. Burns, Gilden, Clardy and Bruce.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Gilden serves as Senior Associate Editor for the Journal of Neurovirology and on the editorial boards of In Vivo, the Journal o

1) Child development following in utero exposure and 2) Topic of the month: Interviews with Dr. Oliver Sacks. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interviews Dr. Gus Baker about his paper on child development following in utero exposure. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about burning mouth syndrome. In the next part of the podcast Dr. Ted Burns interviews Dr. Oliver Sacks about his thoughts about being a patient and a neurologist. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Baker, Fugate and Burns.Dr. Baker has served on a scientific advisory board for sanofi-aventis; serves on the editorial board of Epilepsy and Behaviour; has received speaker honoraria from Eisai Inc.

Plasmapheresis in neurolgic disorders: guideline update and 2) Topic of the month: Interviews with Dr. Oliver Sacks. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann interviews Dr. Irene Cortese about the evidence-based update on plasmapheresis in neurologic disorders. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about triple-a-sign in Lambert Eaton syndrome. In the next part of the podcast Dr. Ted Burns interviews Dr. Oliver Sacks about posterior cortical atrophy and visual agnosias for our Lesson of the Week. Over the next subsequent two weeks, we will continue to discuss other interesting topics with Dr. Oliver Sacks. The participants had nothing to disclose except Drs. Fugate and Burns.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% eff

Repeat brain death examinations and 2) Topic of the month: Interviews with Dr. Oliver Sacks. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Dr. Dana Lustbader about her paper on repeat brain death examinations. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about unilateral photophobia or phonophobia. In the next part of the podcast Dr. Ted Burns interviews Dr. Oliver Sacks about prosopagnosia and the fusiform gyrus for our Lesson of the Week. Over the next subsequent two weeks, we will continue to discuss other interesting topics with Dr. Oliver Sacks. The participants had nothing to disclose except Drs. Kissela, Lustbader Fugate and Burns.Dr. Kissela served on the scientific advisory board for Allergan, Inc in 2009; served as a consultant for Allergan for 2-day meeting in 2009; received honoraria from CME

First paper ever published in Neurology in 1951 and 2) Topic of the month: Interviews with Dr. Oliver Sacks. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Drs. Lewis Rowland, Robert Daroff, and Robert Griggs about the first paper ever published in Neurology on past, present and future of neurology. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about bobble head doll syndrome. In the next part of the podcast Dr. Ted Burns interviews Dr. Oliver Sacks about alexia without agraphia and the left inferotemporal gyrus for our Lesson of the Week. Over the next subsequent three weeks, we will highlight other neurologic disorders Dr. Oliver Sacks writes about in his new book, The Mind's Eye. The participants had nothing to disclose except Drs. Burns, Rowland Griggs and Fugate.Dr. Burns receives a stipend as Podcast Edit

Bihemispheric brain stimulation and 2) Topic of the month: Treatment of tremor in PD. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Drs. Gottfried Schrang and Robert Lindenberg about their paper on bihemispheric brain stimulation. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the clinical syndrome of spinal cord lesions. In the next part of the podcast Dr. Shanna Patterson interviews Dr. Blair Ford for the next part of our discussion on surgical treatment of tremor in PD for our Lesson of the Week. The participants had nothing to disclose except Drs. Kissela, Schlaug, Overman, and Ford. Dr. Kissela served on the scientific advisory board for Allergan, Inc in 2009; served as a consultant for Allergan for 2-day meeting in 2009; received honoraria from CME program and unrestricted educational grants; recei

1) Transient RLS and 2) Topic of the month: Treatment of tremor in PD. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alberto Espay interviews Dr. Mauro Manconi and Prof. Luigi Ferin-Strambi about their paper on transient RLS. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about medullary signs in neuromyelitis optica. In the next part of the podcast Dr. Shanna Patterson interviews Dr. Blair Ford about medical treatment of tremor in PD for our Lesson of the Week. Next week, we will highlight the second part of this interview which will discuss surgical treatment of tremor. The participants had nothing to disclose except Drs. Espay, Overman, Ford and Prof. Luigi Ferin-Strambi. Dr. Espay received has personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, an